Matthew Plunkett Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Plunkett.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Plunkett. Matthew Plunkett is EVP, Chief Business Officer in CTI BIOPHARMA CORP ($CTIC) and EVP, Corporate Development in CTI BIOPHARMA CORP ($CTIC) and Chief Financial Officer in Nkarta, Inc. ($NKTX).
Latest Insider Trading Transactions of Matthew Plunkett
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 31 2014 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Grant | A | 0.00 | 394,199 | 0 | 790,904 | 396.7 K to 790.9 K (+99.37 %) |
Dec 12 2013 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Option Exercise | A | 1.77 | 300,000 | 531,000 | 300,000 | |
Mar 22 2013 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Option Exercise | A | 0.00 | 253,438 | 0 | 253,438 | |
Mar 22 2013 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Grant | A | 0.00 | 296,705 | 0 | 396,705 | 100 K to 396.7 K (+296.71 %) |
Oct 18 2012 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Corporate Deve ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |